Retatrutide: The Next Generation GLP-1 Drug Everyone's Talking About If you thought Ozempic and Wegovy were impressive, the next generation is already in clinical trials and the numbers are stopping researchers in their tracks
However, native GLP-1 has low stability in vivo and is inactivated by the enzyme DPP-4 [34].Two strategies exist for overcoming this problem: first, the development of GLP-1 receptor agonists (GLP-1RAs) that activate GLP-1 receptors similarly to native GLP-1
doi: 10.1056/NEJMoa1901118 256 PerkovicVTuttleKRRossingPMahaffeyKWMannJFEBakrisGet al
The main ingredient is usually berberine, White notes, a substance found in plants that's also been added to products marketed as "GLP-1 supplements." Can You Get GLP-1 in a Patch
The Bigger Picture Retatrutide may represent a major leap forward because it appears to do more than suppress appetite
That means you cannot legitimately place 10.8% for cagrilintide next to 24.2% for retatrutide and declare a winner, because those numbers come from different trials, different populations, different durations (26 vs 48 weeks), different doses, and critically a monotherapy figure for one versus a monotherapy figure for the other, while cagrilintides strongest data are actually as a combination